Several articles with a personal genomics theme popped up today.
Most importantly,
this piece in the Times by Mark Henderson is a superb analysis of the current state and likely future of the personal genomics industry, and a must-read for anyone interested in the field.
Henderson notes that despite the turmoil in the industry in 2009, it’s still unclear which of the disparate models adopted by competitors in the industry (e.g. 23andMe’s curiosity-driven “genomics is fun” approach, or Navigenics’ sombre, paternalistic, health-focused image) will prove the most successful in the long run:
The success or failure of these competing visions will do much to determine the patient experience of the genetic age, and whether direct-to-consumer genomics becomes more than a passing phase. Will we take control of our DNA as individuals, to explore our inheritance, to meet new friends and relatives, and to participate in research? Or will DNA become just another kind of routine medical information, such as cholesterol or blood pressure, which we get through a GP? A lot will depend on which model proves more popular.
Finally, Genomics Law Report’s Dan Vorhaus asks
five questions for personal genomics in 2010 - and nails several of the key areas yet to be resolved as the industry stumbles into its third year, under an economic cloud and facing tremendous financial and regulatory uncertainty.
Enjoy!
Subscribe to Genetic Future.